ICON PLC
NASDAQ:ICLR

  • LAST PRICE
    285.4600
  • TODAY'S CHANGE (%)
    -1.8500 (-0.6439%)
  • Bid / Lots
    285.3600/ 1
  • Ask / Lots
    285.6600/ 2
  • Open / Previous Close
    287.3100 / 287.3100
  • Day Range
    282.8000
    290.4500
  • 52 Week Range
    221.1950
    347.7225
  • Volume
    463,056

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ICLR
ICON PLC
23.8B
33.2x
+4.68%
MRNA
Moderna Inc
25.7B
-4.2x
---
BIIB
Biogen Inc
28.2B
24.1x
-18.14%
GRFS
Grifols SA
7.2B
35.9x
---
BNTX
Biontech SE
28.2B
-51.5x
---
CRL
Charles River Laboratories International Inc
10.2B
23.2x
+15.57%
As of 2024-10-01

Company Information

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Contact Information

Headquarters
South County Business Park LEOPARDSTOWN, Dublin 18DUBLIN, Ireland 00000
Phone
---
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Ciaran Murray
Chief Executive Officer, Director
Stephen Cutler
Chief Financial Officer
Brendan Brennan
Chief Administrative Officer, General Counsel, Company Secretary
Diarmaid Cunningham
Lead Independent Director
Ronan Murphy

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$23.8B
Revenue (TTM)
$8.3B
Shares Outstanding
82.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.22
EPS
$8.60
Book Value
$112.02
P/E Ratio
33.2x
Price/Sales (TTM)
2.9
Price/Cash Flow (TTM)
18.2x
Operating Margin
12.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.